If symptoms of leukemia (blood cancer) are diagnosed in its early stage, the chances of survival and even possibly getting cured completely rises many times.

According to the National Cancer Institute, 43,050 new cases of leukemia were reported in the United States in 2010. 21,840 people died suffering from this cancer.

This article presents the signs of this cancer to watch out for.

Symptoms of Leukemia (Blood Cancer):

There are four types of leukemia. They are Acute lymphocytic leukemia (ALL), Chronic lymphocytic leukemia (CLL), Acute myeloid leukemia (AML) and Chronic myeloid leukemia (CML).

Symptoms of Acute Lymphocytic Leukemia (ALL):

• Bone pain
• Epistaxis
• Anemia
• Metabolic abnormalities
• Fever
• Thrombocytopenia
• Lymphocytosis
• Granulocytopenia
• Nerve palsies

Symptoms of Chronic Lymphocytic Leukemia (CLL):

• Excessive sweating
• Enlarged liver, spleen and lymph nodes
• Abnormal bruising
• Loss of appetite
• Fever
• Fatigue
• Unintentional weight loss
• Recurrent infections

Symptoms of Acute Myeloid Leukemia (AML):

Symptoms of Chronic Myeloid Leukemia (CML):

Conclusion: Complete blood count, bone marrow examination, lymph node biopsy, blood chemistry tests, X-rays, magnetic resonance imaging and computer tomography are some of the diagnostic techniques used to find the above mentioned symptoms of leukemia (blood cancer).

According to the American Cancer Society, one-fifth of leukemia patients remain undiagnosed in spite of these available methods, as the signs are vague, unspecific and mimic symptoms of other ailments.

HOUSTON, Jan. 5 (UPI) — a leukemia drug could prevent destruction of brain cells in Parkinson’s disease, which could lead to ways to slow its progression, U.S. researchers say.

Scientists at the University of Texas Health Science Center discovered a mechanism in Parkinson’s that prevents a protein called parkin from keeping the brain clear of other proteins that can accumulate and kill off cells, The Houston Chronicle reported Tuesday.

Researchers found an enzyme linked to chronic myeloid leukemia blocks parkin from working, and when a leukemia drug was used to block the enzyme it prevented destruction of those healthy cells.

Scientists acknowledge the research is preliminary and the drug used in the experiment with mice doesn’t work well in the human brain, but similar drugs in development might better penetrate the brain and target the specific enzyme at fault more precisely, they say.

About a half-million people suffer from the tremors and stiffness of Parkinson’s, caused by damage to the dopamine-producing cells in the brain.

“The (current) treatments are mostly to improve symptoms,” Syed Imam, UT adjunct assistant professor of medicine, said. “They do not address how to slow down the disease. Our studies were targeted at whether we could actually slow the progression.”